Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,988 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study.
Fujii H, Tsuchiya M, Watanabe D, Otsuka R, Hirate D, Takahashi K, Go M, Kudo T, Shimomura K, Ando Y, Tani S, Takahashi T, Hayashi K, Chin M, Matsunami N, Takahashi M, Hasegawa A, Uchida T, Hashimoto H, Kubo A, Matsuhashi N, Suzuki A, Nishimura J, Inui N, Iihara H. Fujii H, et al. Among authors: hasegawa a. Support Care Cancer. 2024 Apr 17;32(5):291. doi: 10.1007/s00520-024-08498-z. Support Care Cancer. 2024. PMID: 38630197
A phase II study of the safety of olanzapine for oxaliplatin based chemotherapy in coloraectal patients.
Nishimura J, Hasegawa A, Kudo T, Otsuka T, Yasui M, Matsuda C, Haraguchi N, Ushigome H, Nakai N, Abe T, Hara H, Shinno N, Asukai K, Hasegawa S, Yamada D, Sugimura K, Yamamoto K, Wada H, Takahashi H, Omori T, Miyata H, Ohue M. Nishimura J, et al. Among authors: hasegawa s, hasegawa a. Sci Rep. 2021 Feb 25;11(1):4547. doi: 10.1038/s41598-021-84225-6. Sci Rep. 2021. PMID: 33633328 Free PMC article. Clinical Trial.
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
Kikuchi K, Yamazaki N, Nozawa K, Fukuda H, Shibata T, Machida R, Hamaguchi T, Takashima A, Shoji H, Boku N, Takatsuka S, Takenouchi T, Nishina T, Yoshikawa S, Takahashi M, Hasegawa A, Kawazoe A, Masuishi T, Mizutani H, Kiyohara Y. Kikuchi K, et al. Among authors: hasegawa a. Support Care Cancer. 2022 May;30(5):4497-4504. doi: 10.1007/s00520-022-06874-1. Epub 2022 Feb 3. Support Care Cancer. 2022. PMID: 35113224 Clinical Trial.
Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions.
Fukunaga K, Tsukagoshi E, Nakamura R, Matsunaga K, Ozeki T, Watanabe H, Hasegawa A, Hama N, Kurata M, Mizukawa Y, Watanabe Y, Yamaguchi Y, Niihara H, Morita E, Asada H, Abe R, Saito Y, Mushiroda T. Fukunaga K, et al. Among authors: hasegawa a. J Allergy Clin Immunol Pract. 2024 May;12(5):1355-1358.e3. doi: 10.1016/j.jaip.2024.02.041. Epub 2024 Apr 11. J Allergy Clin Immunol Pract. 2024. PMID: 38613561 No abstract available.
Photoemission Orbital Tomography Using a Robust Sparse PhaseLift.
Niki K, Asano R, Sakanoue R, Hasegawa A, Yamada Y, Hagiwara M, Mimura K. Niki K, et al. Among authors: hasegawa a. J Phys Chem A. 2024 Apr 4;128(13):2672-2679. doi: 10.1021/acs.jpca.3c06506. Epub 2024 Mar 26. J Phys Chem A. 2024. PMID: 38530789
1,988 results